查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1744962

全球主动脉瓣市场

Aortic Valves
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 268 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球主动脉瓣市场将达到 98 亿美元

全球主动脉瓣市场规模预计在2024年为61亿美元，预计到2030年将达到98亿美元，2024年至2030年的复合年增长率为8.2%。机械瓣膜是本报告分析的细分市场之一，预计其复合年增长率为7.1%，到分析期结束时将达到58亿美元。生物瓣膜在分析期间内的复合年增长率预计为10.1%。

美国市场规模估计为 17 亿美元，中国市场预计复合年增长率为 12.6%

美国主动脉瓣市场规模预计在2024年达到17亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到21亿美元，在2024-2030年的分析期间内，复合年增长率为12.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.2%和7.8%。在欧洲，预计德国市场的复合年增长率为5.5%。

全球主动脉瓣市场－主要趋势与驱动因素摘要

为什么主动脉瓣对于治疗老化人口结构性心臟病至关重要

主动脉瓣在调节从左心室到主动脉的单向血流中起着至关重要的作用，其功能障碍（通常是狭窄或逆流）会导致严重的心臟疾病和死亡。透过外科手术或经导管进行的主动脉瓣置换术术（AVR）已成为老年结构性心臟疾病患者（尤其是退化性瓣膜疾病）的主要治疗方法。随着全球主动脉瓣狭窄负担的增加和人口老化，主动脉瓣作为恢復心臟功能、缓解症状和提高生存率的救命植入，正日益受到关注。

历史上，外科主动脉瓣置换术(SAVR) 曾是标准治疗方法，需要在心肺体外迴圈进行开胸手术。然而，微创手术—经导管主动脉瓣置换术(TAVR) 的出现彻底改变了治疗模式，扩大了先前被认为无法手术或手术风险高的患者群体的可及性。此后，TAVR 的应用范围已扩展至中低风险族群，强化了其在更广泛患者群体中作为第一线治疗方案的地位。这项变化源自于积极的临床试验数据，这些数据显示，在合适的患者群体中，TAVR 的疗效与 SAVR 相当或更佳。

除狭窄外，主动脉瓣介入治疗在二尖瓣疾病、退化生物瓣膜的瓣中瓣手术以及需要多次瓣膜介入治疗的复杂瓣膜疾病的治疗中也日益受到重视。心臟衰竭、钙化性瓣膜退化盛行率的上升以及无症状性患者筛检的增多，进一步推动了相关手术数量的增长。随着预期寿命的延长以及心血管疾病仍然是全球卫生重点，主动脉瓣置换术仍然是现代心臟病学的关键治疗方法。

设备创新和程序技术如何进步以改善瓣膜性能和患者预后？

瓣膜设计的创新提高了手术瓣膜和经导管瓣膜的动态性能、耐用性和可植入性。由牛或猪心包组织製成的生物瓣膜，如今已采用抗钙化剂处理，并安装在柔性框架上，以减少免疫反应并延长使用寿命。新一代TAVR系统具有可重新定位和回收功能、更细的输送导管以及增强的径向强度，可在高度钙化或二尖瓣主动脉根部等解剖学困难的病例中实现牢固固定。

术前影像学的进步，尤其是多侦测器CT和三维超音波心臟检查，使得病患选择、瓣环大小测定和手术规划更加精准。影像学与数位导航平台和即时萤光透视引导的结合，最大限度地减少了瓣週漏、血管损伤和传导障碍。此外，术中创新，例如脑栓塞保护装置和清醒镇静方案，提高了安全性，并缩短了恢復时间。

耐用性仍然是创新的核心，尤其是在年轻、低风险患者接受经导管主动脉瓣置换术 (TAVR) 的情况下。正在进行的临床试验正在评估瓣膜寿命、瓣膜结构劣化和血栓形成性，以促进其长期应用。基于聚合物的瓣叶设计、组织工程支架和抗血栓涂层正在被研究，以延长瓣膜寿命，突破现有生物瓣膜的限制。同时，标准化瓣中瓣手术、优化小瓣环内的血流动力学以及减少对起搏器的依赖等努力，正在推动器械发展的下一个前沿。

哪些患者族群和地理市场正在推动主动脉瓣介入治疗的需求？

主动脉瓣置换术的主要动力是患有症状性严重主动脉瓣狭窄的老年患者，尤其是在北美和西欧，这些地区的诊断途径、手术基础设施和报销模式都已完善。然而，随着心臟超音波图的筛检应用以及对心臟瓣膜疾病认识的提高，无症状性和中危险群的转诊量正在扩大。对于体弱患者、先前接受心血管手术的患者以及解剖结构复杂、导致开胸手术风险增加的患者，经导管主动脉瓣置换术 (TAVR) 越来越受到青睐。

年轻患者和双尖瓣患者正成为关注的焦点，尤其是在平均诊断年龄较低且报销限制使SAVR成为预设选项的市场。此外，随着第一波组织瓣膜植入开始消退，瓣中瓣领域正在蓬勃发展。这为TAVR修復手术带来了新的需求，而越来越多的证据表明其在再介入中的安全性和有效性。

从地区来看，北美占据最大市场占有率，其次是欧洲，这得益于其高手术量、先进的医疗基础设施和成熟的培训生态系统。亚太地区是成长最快的地区，这得益于医疗保健覆盖面的扩大、人们对心臟瓣膜疾病认识的不断提高，以及中国、印度、日本和东南亚地区私人心血管中心的快速发展。同时，拉丁美洲以及中东和非洲部分地区的应用也受到官民合作关係、医疗旅游以及三级心血管护理基础设施投资增加的支持。

新兴市场在法规、以价值为基础的照护模式和临床证据方面的发展如何影响市场成长？

主动脉瓣膜装置的监管格局正在迅速演变，各机构透过优先审查、突破性疗法认定以及依赖全球临床数据，加速TAVR系统的核准途径。 FDA和EMA等机构正在将器械适应症从高风险患者扩展到中度风险和低风险患者，从而扩大手术合格和保险覆盖范围。上市后监测和註册系统（例如美国的TVT和欧洲的NOTION）正在提供长期疗效数据，以支援持续的报销和纳入指南。

随着医疗保健系统逐渐采用基于价值的模式，成本效益和生活品质的提升已成为技术应用的关键。大量健康经济学研究表明，儘管TAVR的前期成本较高，但它透过降低再入院率、改善功能预后以及降低目标族群的死亡率，提供了长期价值。医院越来越多地根据手术成功率、再次干预风险以及与多学科心臟团队不断发展的治疗方案的兼容性来选择瓣膜平台。

欧洲外科学会 (ESC)、美国心臟协会 (AHA)/美国心臟协会 (ACC) 和美国外科学会 (JCS) 等学会的临床指南正在将 TAVR 纳入针对更广泛患者群体的关键建议中。同时，全球培训工作和跨境知识交流也促进了从业人员的熟练程度和护理标准化。随着疗效的改善以及相关人员对数据驱动决策的需求，临床证据仍将是市场成长和器械製造商策略差异化的关键。

哪些因素推动了主动脉瓣市场的成长？

主动脉瓣市场正经历强劲成长，这得益于全球瓣膜性心臟病发病率的上升、微创介入治疗覆盖范围的扩大，以及以患者为中心、循证循环系统治疗的持续转变。主要驱动因素包括人口老化、筛检增加、治疗指南的不断演变，以及经导管主动脉瓣置换术 (TAVR) 在年轻和低风险族群的广泛应用。从外科手术到导管治疗的转变，在手术量和可及性方面具有特别显着的转变。

随着相关人员寻求个人化、数据主导的治疗途径，技术差异化、长期耐用性和临床多功能性已成为市场竞争力的关键。同时，对混合手术室、专业心臟瓣膜中心以及接受过先进瓣膜疗法培训的跨职能心血管团队的持续投资也为市场扩张提供了支持。随着全球医疗保健系统优先考虑高效、微创和高价值的治疗，主动脉瓣技术正逐渐成为结构性心臟病管理的重要工具。

主动脉瓣市场未来的发展方向将取决于下一代设备如何在不同的医疗环境中有效平衡性能、耐用性和价格。随着精准心臟病学与微创技术的融合，主动脉瓣能否成为全球转型为预防性和恢復性心臟照护的核心节点？

部分

瓣膜类型（机械、生物）、最终用途（医院、门诊手术中心、其他最终用途）

调查企业范例（共34家企业）

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion Inc.
  • AutoTissue GmbH
  • Boston Scientific Corporation
  • CarboMedics Inc.
  • Cardiac Dimensions Inc.
  • Cardiosolutions Inc.
  • Corcym Inc.
  • CryoLife Inc.
  • Edwards Lifesciences
  • Endovalve Inc.
  • Foldax Inc.
  • JenaValve Technology Inc.
  • Leman Cardiovascular
  • LivaNova PLC
  • Medtentia AB
  • Medtronic Plc
  • MiCardia Corporation
  • MitralSolutions Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP34610

Global Aortic Valves Market to Reach US$9.8 Billion by 2030

The global market for Aortic Valves estimated at US$6.1 Billion in the year 2024, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Mechanical Valves, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Biological Valves segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 12.6% CAGR

The Aortic Valves market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Aortic Valves Market - Key Trends & Drivers Summarized

Why Are Aortic Valves Central to the Management of Structural Heart Disease in Aging Populations?

Aortic valves play a vital role in regulating unidirectional blood flow from the left ventricle to the aorta, and their dysfunction-typically stenosis or regurgitation-leads to significant cardiac morbidity and mortality. Aortic valve replacement (AVR), through either surgical or transcatheter approaches, has become a cornerstone intervention in structural heart disease, particularly among elderly patients with degenerative valve conditions. With the global burden of aortic stenosis rising in parallel with aging demographics, aortic valves are increasingly viewed as life-saving implants for restoring cardiac function, relieving symptoms, and improving survival rates.

Historically, surgical aortic valve replacement (SAVR) was the standard of care, requiring open-heart surgery with cardiopulmonary bypass. However, the advent of transcatheter aortic valve replacement (TAVR)-a minimally invasive approach-has transformed treatment paradigms, expanding access to patients previously deemed inoperable or high-risk for surgery. TAVR’s use has since expanded to intermediate and low-risk groups, reinforcing its role as a first-line therapy across broader patient cohorts. This shift is being fueled by favorable clinical trial data demonstrating comparable or superior outcomes relative to SAVR in appropriate candidates.

Beyond stenosis, aortic valve interventions are gaining ground in the management of bicuspid valve disease, valve-in-valve procedures for degenerated bioprostheses, and combined valvular pathologies requiring multi-valve interventions. The growing prevalence of heart failure, calcific valve degeneration, and increased screening in asymptomatic patients is further driving procedural volume. As life expectancy increases and cardiovascular disease remains a global health priority, aortic valve replacement continues to serve as a critical intervention in contemporary cardiology.

How Are Device Innovations and Procedural Technologies Enhancing Valve Performance and Patient Outcomes?

Innovations in valve design are improving hemodynamic performance, durability, and implantability of both surgical and transcatheter aortic valves. Bioprosthetic valves-constructed from bovine or porcine pericardial tissue-are now treated with anti-calcification agents and mounted on flexible frames to reduce immune response and extend lifespan. New-generation TAVR systems offer repositionable and retrievable features, lower-profile delivery catheters, and enhanced radial strength for secure anchoring, even in anatomically challenging cases such as severely calcified or bicuspid aortic roots.

Advancements in pre-procedural imaging, especially multidetector CT and 3D echocardiography, have enabled more precise patient selection, annular sizing, and procedural planning. Integration of imaging with digital navigation platforms and real-time fluoroscopic guidance has minimized paravalvular leak, vascular injury, and conduction disturbances. In addition, intraprocedural innovations such as cerebral embolic protection devices and conscious sedation protocols are improving safety profiles and enabling shorter recovery times.

Durability remains a central focus of innovation, particularly as younger and lower-risk patients undergo TAVR. Ongoing trials are assessing leaflet longevity, structural valve deterioration, and thrombogenicity to support long-term adoption. Polymer-based leaflet designs, tissue-engineered scaffolds, and anti-thrombotic coatings are being explored to extend valve life beyond current bioprosthetic limits. Meanwhile, efforts to standardize valve-in-valve procedures, optimize hemodynamics in small annuli, and reduce pacemaker dependency are pushing the next frontier in device evolution.

Which Patient Segments and Regional Markets Are Fueling Demand for Aortic Valve Interventions?

The primary drivers of aortic valve replacement remain elderly patients with symptomatic severe aortic stenosis, particularly in North America and Western Europe where diagnostic access, procedural infrastructure, and reimbursement models are well-established. However, the increasing use of echocardiographic screening and growing awareness of heart valve disease are expanding referrals even among asymptomatic patients and moderate-risk groups. TAVR is increasingly preferred for frail patients, those with prior cardiac surgery, and those with anatomical complexities that increase open-surgery risk.

Younger patients and those with bicuspid valves are emerging as an important focus, particularly in markets where average age at diagnosis is lower or where SAVR remains the default due to reimbursement constraints. The valve-in-valve segment is also growing rapidly as the first wave of bioprosthetic implants begins to degenerate. This is creating a new layer of demand for redo TAVR procedures, supported by growing evidence of safety and efficacy in reinterventions.

Geographically, North America holds the largest market share, followed by Europe, driven by high procedural volumes, advanced healthcare infrastructure, and established training ecosystems. Asia-Pacific represents the fastest-growing region due to expanding healthcare access, increasing awareness of valvular heart disease, and rapid growth in private cardiovascular centers across China, India, Japan, and Southeast Asia. Meanwhile, adoption in Latin America, the Middle East, and parts of Africa is supported by public-private partnerships, medical tourism, and growing investment in tertiary cardiovascular care infrastructure.

How Are Regulatory Developments, Value-Based Care Models, and Clinical Evidence Influencing Market Expansion?

The regulatory landscape for aortic valve devices is evolving rapidly, with authorities accelerating approval pathways for TAVR systems through priority review, breakthrough designation, and reliance on global clinical data. Agencies such as the FDA and EMA have expanded device indications from high-risk to intermediate- and low-risk patients, driving broader procedural eligibility and insurance coverage. Post-market surveillance and registries-such as TVT in the U.S. and NOTION in Europe-are providing long-term outcomes data that support ongoing reimbursement and guideline inclusion.

As healthcare systems adopt value-based models, cost-effectiveness and quality-of-life improvements are becoming pivotal to technology adoption. Numerous health economic studies have shown that TAVR, despite higher upfront costs, offers long-term value through reduced rehospitalization, improved functional outcomes, and lower mortality in eligible populations. Hospitals are increasingly selecting valve platforms based on procedure success rates, reintervention risk, and compatibility with evolving treatment protocols across multi-disciplinary heart teams.

Clinical guidelines from societies such as the ESC, AHA/ACC, and JCS are incorporating TAVR into mainstream recommendations for a broader patient population. Simultaneously, global training initiatives and cross-border knowledge exchange are supporting operator proficiency and standardization of care. As procedural outcomes improve and stakeholders demand data-backed decision-making, clinical evidence will remain a cornerstone of market growth and strategic differentiation among device manufacturers.

What Are the Factors Driving Growth in the Aortic Valves Market?

The aortic valves market is experiencing robust growth, fueled by the global rise in valvular heart disease, expanded eligibility for minimally invasive interventions, and the continuous shift toward patient-centered, evidence-based cardiovascular care. Key drivers include aging populations, increased screening, evolving treatment guidelines, and growing comfort with TAVR in younger and lower-risk cohorts. The transition from surgical to catheter-based interventions is particularly transformative in terms of procedural volume and accessibility.

Technological differentiation, long-term durability, and clinical versatility are becoming critical to market competitiveness as stakeholders demand personalized, data-driven care pathways. Meanwhile, market expansion is supported by rising investment in hybrid ORs, specialized heart valve centers, and cross-functional cardiovascular teams trained in advanced valve therapies. As global health systems prioritize efficient, minimally invasive, and high-value care, aortic valve technologies are emerging as essential tools in structural heart disease management.

Looking forward, the evolution of the aortic valves market will depend on how effectively the next generation of devices balances performance, durability, and affordability across diverse healthcare settings. As precision cardiology converges with minimally invasive technologies, could aortic valves represent the central node of a global shift toward preventative and restorative heart care?

SCOPE OF STUDY:

The report analyzes the Aortic Valves market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Valve Type (Mechanical Valves, Biological Valves); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion Inc.
  • AutoTissue GmbH
  • Boston Scientific Corporation
  • CarboMedics Inc.
  • Cardiac Dimensions Inc.
  • Cardiosolutions Inc.
  • Corcym Inc.
  • CryoLife Inc.
  • Edwards Lifesciences
  • Endovalve Inc.
  • Foldax Inc.
  • JenaValve Technology Inc.
  • Leman Cardiovascular
  • LivaNova PLC
  • Medtentia AB
  • Medtronic Plc
  • MiCardia Corporation
  • MitralSolutions Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Aortic Valves - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Aortic Stenosis and Valve Disease Throws the Spotlight on Aortic Valve Replacement
    • Growth in Transcatheter Aortic Valve Replacement (TAVR) Procedures Spurs Minimally Invasive Treatment Demand
    • OEM Innovations in Tissue-Engineered and Self-Expanding Valves Strengthen Market Penetration
    • Increasing Use of Bioprosthetic Valves in Aging Populations Supports Shift Away From Mechanical Alternatives
    • Expansion of Valve-in-Valve Procedures Bodes Well for TAVR in Failed Surgical Valve Replacements
    • Advancements in Imaging-Guided Implantation Improve Procedural Accuracy and Clinical Outcomes
    • Growth in Aortic Valve Clinics and Multidisciplinary Heart Teams Enhances Patient Selection and Preoperative Planning
    • Rise in Early Intervention Guidelines and Lower-Risk Patient Approvals Accelerates Market Growth
    • Integration of AI and Predictive Modeling Supports Personalized Valve Selection and Post-Procedure Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Aortic Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mechanical Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biological Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION